BriaCell Therapeutics BCTX Cash Flow Statement (2019-2026)

NASDAQ BCTX
$3.93 -0.02 (-0.51%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Aug2019 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating Activities
Net Income (Quarter)
-2.77M-2.28M-3.87M-4.84M-5.15M-5.32M-6.37M-7.49M-7.50M-8.35M-9.75M-9.21M-5.77M-5.18M-7.12M-6.34M-8.48M-8.32M-7.43M-7.43M
Depreciation and Depletion (Quarter)
0.02M0.02M0.02M0.02M0.02M0.02M0.03M
Share-based Compensation (Quarter)
-0.04M0.52M0.81M5.59M0.88M1.11M0.27M0.28M0.53M0.53M0.50M0.39M0.38M0.27M0.64M0.22M1.73M0.29M0.43M
Gains from Investment Securities (Quarter)
25.25M-14.80M5.93M-4.73M-4.12M7.63M-0.54M-5.09M-14.28M1.57M-10.95M-4.58M0.62M-0.81M-0.18M-0.39M0.07M-0.21M-0.12M
Cash from Operations (Quarter)
-1.95M-1.78M-2.56M-4.82M-3.33M-3.54M-3.95M-5.33M-10.92M-7.61M-7.40M-5.08M-4.04M-6.96M-5.92M-7.16M-8.13M-7.70M-7.97M-7.02M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.06M0.02M0.02M0.03M0.01M0.02M0.02M0.03M
Change in Working Capital
Change in Receivables (Quarter)
-0.02M0.01M0.01M-0.01M0.01M0.01M-0.02M0.01M0.00M0.00M0.01M-0.01M0.74M-0.74M0.01M-0.01M-514.00
Change in Account Payables (Quarter)
0.31M0.03M0.28M-0.31M0.24M0.33M-0.21M0.41M0.13M-0.69M3.28M2.71M0.75M-2.94M0.77M-1.72M0.00M-1.15M-0.25M0.29M
Change in Accured Expenses (Quarter)
-0.15M-0.11M0.07M0.33M-0.30M-0.09M0.30M0.29M-0.07M-0.40M0.12M-0.04M0.46M-0.18M0.82M-0.36M0.49M0.12M0.11M
Investing Activities
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-0.46M-0.07M-0.07M-0.10M-7.39M-0.07M7.28M-16.00M
Financing Activities
Other financing activities (Quarter)
1.38M0.29M0.53M
Change in Capital Stock
Shares Issued (Quarter)
0.67M1.49M1.67M1.67M1.69M2.13M2.13M2.13M2.13M0.01M2.13M0.15M0.13M0.01M0.05M0.05M0.34M
Net Equity Issued and Repurchased (Quarter)
11.67M4.69M14.71M13.56M
Misc.
Cash from Financing Activities (Quarter)
38.29M1.37M-0.16M-0.05M0.00M4.00M11.96M5.22M14.71M13.56M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
36.35M-1.78M-7.51M-3.45M-3.49M-3.59M-3.95M-5.33M-6.92M-7.61M-7.40M-5.31M-0.07M4.93M-0.78M7.45M-1.97M-7.78M27.19M-23.02M
Free Cash Flow (Quarter)
-1.95M-1.78M-2.56M-4.82M-3.33M-3.54M-3.95M-5.33M-10.92M-7.61M-7.40M-5.08M-4.04M-6.96M-5.92M-7.16M-8.13M-7.70M-7.97M-7.02M
Net Cash Flow (Quarter)
36.35M-1.78M-2.56M-3.45M-3.49M-3.59M-3.95M-5.33M-6.92M-7.61M-7.40M-5.08M-4.49M4.93M-0.78M7.45M-1.97M-7.78M-0.68M-23.02M